EFTR | eFFECTOR Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0002 - 0.0002
52 Week Range	0.0001 - 17.90
Beta	1.60
Implied Volatility	477.29%
IV Rank	48.95%
Day's Volume	202,090
Average Volume	36,757
Shares Outstanding	4,704,410
Market Cap	941
Sector	Healthcare
Industry	Biotechnology
IPO Date	2021-03-01

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	-12.57
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	14
Country	USA
Website	EFTR

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK1/2 that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer (NSCLC). The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 1/2 clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. The company was founded in 2012 and is headquartered in San Diego, California.

EFTR's peers: ACIU, AFMD, ALLR, APM, ATNF, AVIR, BCTX, BNTC, BTAI, CELU, CNSP, CRDF, CYTO, DRMA, DRUG, ENVB, EVAX, GERN, GNPX, GOVX, HEPA, IBRX, IMMP, IMMX, INVA, JAGX, LEXX, LPTX, LXRX, MREO, NBTX, NBY, NCNA, PALI, PDSB, PHGE, PHIO, PLX, PYPD, PYXS, RIGL, RNAZ, RXRX, SLS, SNGX, SONN, SYBX, VTGN, VTVT, XERS, XFOR, BIOR, CDIO, ICU, CMND, ZVSA, OCEA, CARM

*Chart delayed

Analyzing fundamentals for EFTR we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see EFTR Fundamentals page.

Watching at EFTR technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on EFTR Technicals page.